Paraneoplastic neurologic syndromes: Pathogenesis and physiopathology Journal Article


Authors: Dalmau, J.; Gultekin, H. S.; Posner, J. B.
Article Title: Paraneoplastic neurologic syndromes: Pathogenesis and physiopathology
Abstract: Since 1965 when the first paraneoplastic antineuronal antibody was reported by Wilkinson and Zeromski (55), the number of immunological responses detected in association with paraneoplastic syndromes of the nervous system has steadily increased, These responses are characterized by the presence of antineuronal antibodies in serum and CSF and/or infiltrates of T-cells in the tumor and nervous system, A few syndromes are mediated by antibodies; they include those resulting from dysfunction of the neuromuscular junction at the pre- or post-synaptic level (Lambert-Eaton myasthenic syndrome, myasthenia gravis) or ion channel dysfunction in the peripheral nervous system (i.e, Voltage-gated potassium channel and neuromyotonia), In most other paraneoplastic syndromes, including those involving the central nervous system, the pathogenic role of highly specific antineuronal antibodies (anti-Hu, anti-Yo, etc) has not been established; nevertheless these antibodies should be regarded as useful markers of specific paraneoplastic syndromes and tumors, Moreover, there is increasing evidence that in some of these syndromes T-cell mediated mechanisms can cause the neurologic dysfunction and contribute to tumor rejection. Some paraneoplastic syndromes are caused by the tumor secretion of antibodies (macroglobulinemia and MAG antibodies), hormones, and cytokines, In other instances, the tumor may compete with the nervous system for an essential substrate (glucose, tryptophan) and result in neurologic dysfunction.
Keywords: cell lung-cancer; central-nervous-system; immunohistochemical analysis; cerebellar; amyotrophic-lateral-sclerosis; degeneration; eaton-myasthenic-syndrome; anti-hu antibody; encephalomyelitis sensory neuronopathy; recombinant yo protein; passive transfer
Journal Title: Brain Pathology
Volume: 9
Issue: 2
ISSN: 1015-6305
Publisher: Blackwell Publishing  
Date Published: 1999-04-01
Start Page: 275
End Page: 284
Language: English
ACCESSION: WOS:000079476300009
PROVIDER: wos
PUBMED: 10219745
DOI: 10.1111/j.1750-3639.1999.tb00226.x
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jerome B Posner
    211 Posner
  2. Josep O Dalmau
    101 Dalmau